Compounds > cp 65,526

Page last updated: 2024-09-03

cp 65,526 and cyclosporine

cp 65,526 has been researched along with cyclosporine in 5 studies

Compound Research Comparison

Studies (cp 65,526)	Trials (cp 65,526)	Recent Studies (post-2010) (cp 65,526)	Studies (cyclosporine)	Trials (cyclosporine)	Recent Studies (post-2010) (cyclosporine)
65	1	5	30,547	3,802	6,558

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (80.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beliveau, R; Jetté, L; Leclerc, JM; Murphy, GF	1
Beaulieu, E; Béliveau, R; Jetté, L; Leclerc, JM	1
Ambudkar, SV; Dey, S; Gottesman, MM; Pastan, I; Ramachandra, M	1
Béliveau, R; Jetté, L; Murphy, GF	1
Melera, PW; Song, J	1

Other Studies

5 other study(ies) available for cp 65,526 and cyclosporine

Article	Year
Interaction of drugs with P-glycoprotein in brain capillaries. Biochemical pharmacology, 1995, Nov-09, Volume: 50, Issue:10 Topics: Affinity Labels; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Blood-Brain Barrier; Brain; Capillaries; Cyclosporine; Cyclosporins; Drug Interactions; Glycerol; In Vitro Techniques; Iodine Radioisotopes; Male; Prazosin; Rats; Rats, Sprague-Dawley; Time Factors; Tritium	1995
Cyclosporin A treatment induces overexpression of P-glycoprotein in the kidney and other tissues. The American journal of physiology, 1996, Volume: 270, Issue:5 Pt 2 Topics: Administration, Oral; Affinity Labels; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Cyclosporine; Cyclosporins; Immunosuppressive Agents; Injections, Subcutaneous; Kidney; Male; Microvilli; Prazosin; Rats; Rats, Sprague-Dawley; Time Factors	1996
Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein. Proceedings of the National Academy of Sciences of the United States of America, 1997, Sep-30, Volume: 94, Issue:20 Topics: 3T3 Cells; Affinity Labels; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Binding Sites; Biological Transport; Cell Line; Cyclosporine; Flupenthixol; Humans; Insecta; Iodine Radioisotopes; Mice; Models, Biological; Prazosin; Radioligand Assay; Vanadates; Vinblastine	1997
Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment. International journal of cancer, 1998, May-29, Volume: 76, Issue:5 Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Blotting, Western; Brain; Calcium Channel Blockers; Capillaries; Cyclosporine; Cyclosporins; Drug Interactions; Fluorescent Dyes; Injections, Subcutaneous; Iodine Radioisotopes; Kidney; Liver; Male; Microvilli; Photoaffinity Labels; Prazosin; Rats; Rats, Sprague-Dawley; Rhodamine 123; Rhodamines; Verapamil; Vinblastine	1998
Transmembrane domain (TM) 9 represents a novel site in P-glycoprotein that affects drug resistance and cooperates with TM6 to mediate [125I]iodoarylazidoprazosin labeling. Molecular pharmacology, 2001, Volume: 60, Issue:2 Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Binding, Competitive; Cells, Cultured; Cricetinae; Cyclosporine; Drug Interactions; Drug Resistance; Drug Resistance, Multiple; Iodine Radioisotopes; Membrane Proteins; Mutagenesis, Site-Directed; Prazosin; Protein Structure, Tertiary; Transfection; Verapamil	2001